Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00868621 · ClinicalTrials.gov registry record
Urinary Cytokines in Patients With Overactive Bladder (OAB)
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT00868621 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT00868621 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Overactive bladder (OAB) is a widespread condition characterized by urgency, urge incontinence, nocturia and excessive urinary frequency, affecting millions of people worldwide. In two epidemiological studies, OAB was found in about 17% of American and European populations. This accounts for an estimated 33 million patients suffering from OAB in the USA. The disorder constitutes a psychological stress that impacts the patient's social life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00868621
The ClinicalTrials.gov registry entry for NCT00868621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00868621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00868621 about?
NCT00868621 is a clinical study titled "Urinary Cytokines in Patients With Overactive Bladder (OAB)". Overactive bladder (OAB) is a widespread condition characterized by urgency, urge incontinence, nocturia and excessive urinary frequency, affecting millions of people worldwide. In two epidemiological studies, OAB was found in about 17% of American and European populations. This accounts for an esti...
What is the current status of trial NCT00868621?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-03. Estimated completion is 2009-08.
Who is sponsoring clinical trial NCT00868621?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.